Evidence map›Paper›PMID 41585808›Full record

ArticleFrontiers in endocrinology2025

Case report: From metabolic instability to remission: a case of pheochromocytoma presenting as atypical diabetes.

Chuqing Cao, Pingyan Xue, Xuefeng Yang, Fansu Huang, Yuting Xie, Zhiguang Zhou

Abstract readCase Reports
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chuqing CaoDepartment of Metabolism and Endocrinology, Key Laboratory of Diabetes Immunology (Ministry of Education), National Clinical Research Center for Endocrine and Metabolic Diseases, The Second Xiangya Hospital of Central South University, Changsha, China.
Pingyan XueDepartment of Metabolism and Endocrinology, The Second People's Hospital of Qujing City, Yunnan, Qujing, China.
Xuefeng YangDepartment of Nuclear Medicine, The Second Xiangya Hospital of Central South University, Changsha, China.
Fansu HuangDepartment of Clinical Nutrition, National Clinical Research Center for Endocrine and Metabolic Diseases, The Second Xiangya Hospital of Central South University, Changsha, China.
Yuting XieDepartment of Metabolism and Endocrinology, Key Laboratory of Diabetes Immunology (Ministry of Education), National Clinical Research Center for Endocrine and Metabolic Diseases, The Second Xiangya Hospital of Central South University, Changsha, China.
Zhiguang ZhouDepartment of Metabolism and Endocrinology, Key Laboratory of Diabetes Immunology (Ministry of Education), National Clinical Research Center for Endocrine and Metabolic Diseases, The Second Xiangya Hospital of Central South University, Changsha, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Pheochromocytoma is a well-established cause of secondary hypertension and can lead to dysglycemia. However, its initial presentation as atypical diabetes, characterized by severe glycemic instability, is uncommon and poses a significant diagnostic challenge. Case presentation: A 49-year-old non-obese Chinese woman presented with a 15-month history of progressive polyuria and polydipsia. Initially diagnosed with type 2 diabetes, she developed significant glycemic variability with recurrent hypoglycemia and profound hyperglycemia, alongside a rapid decline in β-cell function. During hospitalization, paroxysmal hypertension was observed. Biochemical testing confirmed markedly elevated catecholamines and metabolites. Imaging identified a left adrenal mass, confirmed as pheochromocytoma following laparoscopic adrenalectomy. Postoperatively, all antidiabetic medications were discontinued. At 3-month follow-up, she achieved sustained normoglycemia with restored β-cell function and normalized blood pressure. Conclusions: This case demonstrates that pheochromocytoma can induce a severe, reversible form of diabetes characterized by profound metabolic instability and marked glycemic variability. It highlights the necessity of including pheochromocytoma in the differential diagnosis of patients with atypical, labile diabetes, especially when paroxysmal symptoms are present. Early surgical intervention can reverse these metabolic derangements, often leading to diabetes remission.

Indexed as

Adrenal Gland NeoplasmsDiabetes Mellitus, Type 2PheochromocytomaAdrenalectomyDiagnosis, DifferentialFemaleHumansHypertensionMiddle AgedRemission Inductionadrenalectomyatypical diabetespancreatic β-cell functionpheochromocytomasecondary diabetes

Identifiers

PMID41585808
PMCPMC12827098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.